Health, Safety and Environment (HSE) in Brazil
Brazil’s National Health Surveillance Agency (ANVISA), has announced an upcoming update to regulations concerning in vitro diagnostic devices (IVD). This move aims to modernize and enhance the regulatory framework to ensure the safety, efficacy, and quality of these crucial healthcare Read More …
Brazil’s National Health Surveillance Agency (ANVISA) has initiated the process of gathering contributions for new regulations governing epidemiological surveillance activities at ports and airports. This regulatory update aims to bolster Brazil’s preparedness and response capabilities to health emergencies, particularly those Read More …
The Brazilian Health Regulatory Agency (ANVISA) recently approved a Regulatory Impact Analysis (RIA) report on medical cannabis. This development marks an important step towards the potential reshaping of cannabis regulations in Brazil, promising wide-ranging implications for public health, medical research, Read More …
Brazil’s Health Regulatory Agency (Anvisa) has commenced sample collections for the 2024 cycle of the Program for the Pesticide Residue Analysis in Food (Programa de Análise de Resíduos de Agrotóxicos em Alimentos – PARA). This initiative is crucial for monitoring Read More …
Brazil’s National Health Regulatory Agency (Agência Nacional de Vigilância Sanitária – Anvisa) has recently updated its list of Brazilian Common Denominations (Denominações Comuns Brasileiras – DCB), an essential step for the standardization and regulation of pharmaceutical substances in Brazil. The Read More …
The latest release of Brazilian Health Regulatory Agency’s (ANVISA) “Labeling of Allergenic Foods” guidance in its sixth edition demonstrates the agency’s commitment to ensuring consumer safety and public health through enhanced allergen labeling standards. This revision places a strong emphasis Read More …
The Brazilian National Health Regulatory Agency (Anvisa) has announced a new initiative to expedite the certification process for Good Manufacturing Practices (GMP). In a move towards greater regulatory reliance, Anvisa will now consider inspections conducted by equivalent foreign regulatory bodies Read More …
Brazil’s National Health Regulatory Agency (ANVISA), has introduced new subject codes to facilitate the registration and updating of pre-pandemic influenza vaccines. These codes align with Resolution RDC No. 846/2024, which outlines the conditions and procedures for registering and updating vaccine strains Read More …
The Brazilian Health Regulatory Agency (Anvisa) upheld the prohibition on electronic smoking devices (ESDs), commonly known as electronic cigarettes. The decision is the outcome of a regulatory process that reviewed the regulation of these products in the country in light Read More …
ANVISA has launched Call No. 1, aimed at supporting the development of phytotherapeutic drugs, new synthetic drugs and biological products of interest to healthcare services by medical startups. Recognizing the critical need for new medications and the importance of nurturing Read More …